All News

By joining forces, the two companies will be able to bring Dispersome to the market faster for novel drug development

The two transactions enable Recipharm to expand its ATMP offering into virotherapies and boost its US biologics services

 $40 million expansion will support increased production of single-use technology for critical vaccines and biologics

The biopharma industry drives development of complex therapies which improve the health outcomes and quality of life of patients across the globe. It is however a significant contributor to environmental waste and emissions as a direct result of it'...

MediCane Health's EU-GMP certification helps to bridge the pharma-cannabis gap

A diverse range of sectors and industries come together in partnership to address infection management, advocating a whole system approach

Formulating a drug for parenteral delivery comes with its fair set of challenges. Aside from a high level of sensitivity to external factors like light and heat exposure, these large and complex drugs are prone to degradation when exposed to various ch...

Travel restrictions imposed by the pandemic have limited the ability of pharmaceutical companies and health authority personnel to travel and conduct in-person inspections of contract manufacturing organizations (CMOs).  Due to t...

COVID-19 saw biopharma turn to single-use technology in a big way. But greater use of disposable manufacturing systems does not necessarily mean drug and vaccine production has become less environmentally sustainable.

The investment covers two expansions to accommodate several pipeline products moving to commercial scale

Cardinal Health says the majority of healthcare providers are keen to use biosimilars despite current market challenges

Adjuvants. You’ve seen them on our website. You’ve seen them featured in our blog articles. Now we want to show you how Avanti’ & Croda-Denmark can enhance your vaccine adjuvant research! Keep reading to learn more!

Speakers from the European Fine Chemicals Group, the voice of fine chemical manufacturers in Europe, led a discussion on the ‘globalised, fragmented and complex’ API and raw materials supply chain, in this month’s edition of the CPHI ...

The $1.5 billion investment will fund a parenteral manufacturing facility in North Carolina and a biopharmaceutical manufacturing site in Ireland

Initial Public Offerings totalled £1,304 million, an increase of 434% from 2020, but more needs to be done to connect the UK's life sciences and finance sectors

Samsung Biologics has reached an agreement for the buyout of Biogen’s stake in the Samsung Bioepis joint venture for USD $2.3 billion.

Xpress Pharmaceutics will facilitate adaptive clinical trials and reduce the time taken to complete FIH studies

The collaboration includes a multimillion-dollar investment to expand glass technology that will advance packaging and delivery systems

The latest coronavirus updates and developments impacting the global pharmaceutical supply chain. Includes the latest news surrounding the therapeutic developments, updates to vaccines and boosters, and the global pharmaceutical regulations that need t...

The medical journal highlights antimicrobial resistance (AMR) to be a 'leading cause of death around the world'.

The agreement will enable millions of patients in more than 100 low- and middle-income countries to gain access to molnupiravir

Last year the company reduced its electricity requirements by 40%

The CDMO will provide expertise and capacity to advance BravoBio's vaccine pipeline

A quarterly series blog posts about responsible supply chain management from the PSCI Chair, Manjit Singh

Lagevrio and Paxlovid are the only COVID-19 pills cleared for emergency use at present, but others are coming with developers racing to bring oral antivirals to this potentially lucrative market.

The move is expected to bring added value to customers by coupling biology services with existing chemistry capabilities

In this month’s CPHI podcast, sponsored by Galien Pharma, we focus on the technology behind orally dissolving tablets.

This second facility gives the company a significant power multiplier for export capacity and geographical reach

We are approaching the end of a year which saw global vaccine rollout for COVID-19, 44 novel drug approvals (to date) and the return of the CPHI Worldwide in-person event.

Transaction adds new technologies and capabilities in large molecules, including vaccines and gene therapy, to its global offering

This white paper is a retrospective analysis on how the new generation of Molly autoinjectors have incorporated a greater level of flexibility in its design and development model.

New campus will support the company as it approaches potential commercialisation of its rapidly progressing clinical candidates

CDMO currently manufacturing LAAB combination treatment  and will start on cancer immunotherapy product from next year

During the recent CPHI Webinar Packaging & Drug Delivery Trends for 2022 sponsored by Portal Instruments, experts discussed the crucial factors to consider during the development process, such as digitalisation, sustainability and a shift towards self-...

Merck will design the manufacturing process to help accelerate self-sufficient vaccine development and manufacturing in West Africa

The new agreement extends to 2028 and allows Oxord Biomedica to work with other potential partners across all CAR-T targets

The dedicated pharma trade lane will unite key compliant and sector-certified supply chain stakeholders and help Abu Dhabi to strengthen its capabilities as a life sciences hub

The new facility will focus on the research of excipients for oral dosage forms, drug delivery systems, nutraceutical APIs and innovative pharma ingredients

CPHI has launched its forward-looking pharma trend report for 2022 and it is now available to read on CPHI Online.

A 30,000-sq. ft cGMP facility and a separate R&D site will work alongside each other to provide end-to end product development solutions for Singapore and low- and middle-income countries

The facility will be the first to use Evolve’s innovative PlasmaCap EBA technology to produce plasma-derived therapeutics

The combined company intends to lead in the space of oral formulations, solving customers' complex formulation challenges

It could take pharmaceutical companies months to tweak their COVID-19 vaccines to provide sufficient protection against the Omicron variant of the coronavirus if it poses a risk of serious illness.

The new route uses a novel enzyme, cytidine aminotransferase, which would reduce the manufacturing cost of the drug

Lyophilisation or freeze drying is an important means to improve thermal stability of a drug product, according to Thomas Becker, Quality Director and Qualified Person, Recipharm. This is particularly true for those that are thermolabile, such as mRNA ...

The offering will accelerate timelines for the development and manufacturing of molecules and disruptive technologies

The expansion is expected to make the company the largest CDMO in oligonucleotide production in 2025

The new 31,000-sq. ft building will bring additional commercial spray drying capacity for customers who favour US-based manufacturing

In this special edition podcast, Informa Markets pharma editor Gareth Carpenter speaks to Bikash Chatterjee, CEO at Pharmatech Associates and Dan Stanton, Editor and Founder at BioProcess International about some of the findings in the recently pu...

The transaction expands ANI’s R&D pipeline and adds nine new customers to its growing CDMO business

The facility's total 60,000-L capacity supports growing demand for manufacture of late-phase and commercial projects

China is the pharma industry’s biggest gainer in the 2021 CPHI Annual Rankings, with digital matchmaking driving new waves of partnerships

CPHI Verified certification improves supply chain transparency, providing a legal, regulatory and quality benchmark

New Zebra study shows the pharmaceutical industry has a trust problem, but industry leaders say they’re trying to become more transparent

The expansion includes the installation of a pilot suite with a 50-L fermenter and automation upgrades to accelerate clinical and commercial projects

SK's financial backing enables CBM to address significant capacity constraints in the cell and gene therapy manufacturing space

The proposed state-of-the-art facility could potentially produce up to 100 million vaccine doses each year for Australians

Company says it has concluded virus is in endemic phase and it is the ‘right time’ to switch

WuXi will use its new modality platform to provide an end-to-end solution for oligonucleotide peptide

Awards seek to recognise ‘Excellence in Pharma’, assessing entries from the industry’s leading companies and individuals.

The $20.1 million investment will enable the company to manufacture pharma products for the Adcock Ingram Group and for other clients

The transaction will support Cannabics' planned IND fillings and Phase I/II (a) clinical trials

The first-of-its-kind centre will offer biopharma clients convenience and efficiencies in the rapidly expanding Northeast

The increasing outsourcing trend among pharmaceutical companies represents a promising opportunity for CDMOs. This panel discussion at CPHI Worldwide touched upon some of the opportunities, hurdles, and trends ahead for the CDMO market

Expected increase in approvals for gene therapies, gene-modified cell therapies and recombinant vector vaccines will also increase pressure on manufacturers to build new capacity

The CDMO says the suite will help to "bring back manufacturing to the US"

The companies will establish a Centre of Excellence focused on exosome manufacturing and characterization technologies

The concept of patient centricity has many nuances, and designing dosage forms needs to be underpinned by a multi-functional perspective utilised as early as possible, say experts

Upcoming Late Stage Bioprocessing & Viral Vectors Digital Week running 2-11 November will address many goals and challenges associated with optimizing biologics manufacturing through different stages of the process

A new in-person and online edition of CPHI Worldwide, transforming your event experience.

The CDMO's services will help to advance clinical testing of Clearmind's drug candidate for treating alcohol use disorder

Clients to receive accelerated quality testing and reduced turnaround times

Rather than looking back at what has been a challenging past few months, this Trend Report - featuring highlights from the Pharmapack 2021 content programme - has been written very much in the spirit of looking forward and addressing the key challenges...

Rise of innovative companies with high-risk portfolios will necessitate need for CDMOs, says Thermo Fisher senior executive

By completion at the end of 2022, the campus will accommodate 18 cGMP viral vector manufacturing suites

COVID-19 pandemic has exposed weaknesses and sector faces new challenges driven by rising costs of production in China

Current EU regulatory systems too overwhelmed by paper, head of European association representing generics, biosimilars and value added medicines industries tells CPHI Worldwide online conference

Country expected to grow threefold over the next decade due to increased focus on complex generics, biosimilars and specialty products

One site will focus on microbial production, the other on small-scale mammalian-based production

Milan is home to an internationally competitive pharmaceutical, biotechnology and functional foods hub, with strong growth prospects and a commitment to innovation across its entire supply chain. Italy is also home to one of the most advanced and ...

The CDMO will supply expertise in GMP sterile fill-finish manufacturing and controlled-substances

As a network member, the company hopes to help reduce the US's reliance on overseas imports by providing domestic API capability

According to unnamed sources in Politico report, company’s vaccine batches have not met FDA purity level standards

UCB Pharma is informed by agency that action on application for psoriasis treatment is being deferred until on-site visits can be made

In complete response letter, agency cites single deficiency at third-party facility that performs analytical testing of Treprostinil drug substance

Together the companies will attempt to overcome "black box" challenges to enable more robust and consistent results for clients

The move, coupled with the plants's passing of a pharmaceutical GMP compliance inspection, will enable company to accelerate the R&D of its novel Advanced TCMPs

The biologics CDMO says it expects its new 53,000-sq.ft facility will be operational within 18 months

Manufacturer starts development of API for molnupiravir, which is set to become world’s first oral treatment against coronavirus

Awards showcased a wide range of industry-changing innovations in packaging and drug delivery, with sustainability emerging as a key metric across all categories

Panel discusses how healthcare institutions are adapting to calls for more sustainability in various processes in the value chain

The transaction expands the CDMO's GMP biopharmaceutical and vaccine manufacturing capabilities

The new the 140,000-sq. ft facility will support commercialisation and industrialisation of viral vectors

Having acquired a 53,000 sq-ft property in Berlin, the company plans to set up new laboratories, production and cleanrooms

The COVID-19 pandemic has meant scientists, together with pharmaceutical companies, have had to reinvent how to bring vaccines to market faster without impacting product quality, safety, or efficacy, according to experts speaking at a recent CPHI webin...

Pre-filled syringes (PFS) could help immensely in solving the challenges of rolling out future mass vaccination campaigns, according to experts at Becton Dickinson (BD).

During the live Innovation in Connectivity Roundtable at the Pharmapack 2021 online conference, experts discussed how the latest innovations in digital technology are shaping industry ambitions to put the patient journey at the heart of its drug device...

The LSCC provides an additional 30% in mammalian large-scale capacity for the company's own pipeline and for third parties

Just as 'food miles' have become a key concern among consumers in recent years, patients now want to know more about 'medicine miles', study commissioned by Teva finds

Electronic devices and connectivity are being progressively included in drug delivery devices, bringing positive outcomes to all stakeholders, according to drug device combinations specialist, Nemera Tuesday

Traceability of medicines can help to reduce the negative effects to pharmaceutical supply chains of counterfeit medicines, medication errors and drug shortages, Nathalie Wardé-Dunoyer, CEO & Founder of Swiss start-up, D4P pharma told the Pharma...

The $85 million Iovance Cell Therapy Center (ICTC) has opened its doors at the Philadelphia Navy Yard with capacity to supply thousands of patients per year.

Quantum computing technology uses quantum systems called “qubits”. They work with non-binary values, unlike classical computing which uses only bits with values of 0 or 1, and can overlap each other and act as a group. The result is a ...

Responding to critical market capacity constraints, Thermo Fisher announces the official opening of new 67,000 sqft cGMP plasmid DNA manufacturing facility in Carlsbad, CA. This site expands clinical and commercial capabilities for cGMP plasmid DNA use...

By providing AAV process development, scale up and cGMP manufacturing services, Forge hopes to bolster Solid's gene therapy pipeline

The transaction will generate $102.25 million to support the company's product pipeline and scaling up commercial activities for Afrezza

New facility aims to serve local and global pharmaceutical customers with high-purity ethanol, ethanol blends and buffer solutions

Shawn Branning, Global Strategic Marketing Manager at IFF – Pharma Solutions

Catch up on the latest trends and developments in orally disintegrating tablet (ODT) formulation development

Biocatalytic processing offers a wealth of advantages and should be evaluated during early-stage drug development for its potential to improve yields, increase efficiency, and support greener manufacturing.

The facility will increase the production capacity of cell culture media products and provide a hub for European and global markets

In France, rare diseases are numerous: between 7,000 and 8,000 diseases are currently accounted for, and concern more than 3 million French people, accounting for almost 4,5% of the total population. The organization of screening and care for these ill...

The company plans to open a new 130,000-sq. ft plant in Ann Arbor in late 2023

The acquisition will add 13 approved products and additional pipeline products

Only 0.3% of the 5.76 billion doses administered worldwide have been distributed to low-income countries

The private investment firm plans to acquire SEQENS and merge it with Wavelength Pharmaceuticals

Pharmapack Europe is back! Join us online from 27 September as we kick off our two-week long content programme, a great precursor to the in-person event from 13-14 October at the Paris Expo Porte de Versailles.

As a safe, effective and convenient way to administer injectable medications, pre-filled syringes (PFS) have become the injection system of choice for a growing number of drugs. PFS allow healthcare professionals to easily handle syringes, reduce waste...

The company's new Gibco AAV-MAX Helper Free AAV Production System helps reduce production costs and streamline transition from research to clinical environments

The CDMO will provide commercial manufacturing and packaging services for Phathom's novel, orally active P-CAB